Investor Alert

New York Markets Open in:

Horizon Therapeutics PLC



After Hours

 --Quotes are delayed by 20 min

May 24, 2022, 6:12 p.m.





+0.90 +1.02%


Volume 193,421

Quotes are delayed by 20 min


Previous close

$ 87.38

$ 88.03


+0.65 +0.74%

Day low

Day high




52 week low

52 week high




Elizabeth H. Z. Thompson

Currently, Elizabeth H. Z. Thompson occupies the position of Executive Vice President-Research & Development at Horizon Therapeutics Plc.

Dr. Thompson previously held the position of Group Director-Scientific Clinical Development at AbbVie, Inc.

Dr. Thompson received an undergraduate degree from Harvey Mudd College and a doctorate from The Scripps Research Institute.


Date Shares Transaction Value
04/18/2022 8,098   Disposition at $115.64 per share. 936,453
01/05/2022 7,030   Derivative/Non-derivative trans. at $101.84 per share. 715,936
01/05/2022 13,999   Derivative/Non-derivative trans. at $0 per share. 0
08/05/2021 7,542   Disposition at $106.34 per share. 802,017
07/01/2021 5,988   Derivative/Non-derivative trans. at $96.59 per share. 578,381
07/01/2021 12,077   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.